Factor II, VII, IX and X concentrations in patients receiving long term warfarin.
- 1 January 1987
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 40 (1) , 94-98
- https://doi.org/10.1136/jcp.40.1.94
Abstract
Using standard one stage clotting assays the concentrations of factors II, VII, IX and X were determined in 37 patients stabilised on warfarin for between three months and 17 years. Contrary to popular belief, the concentrations were not equally depressed, with factor X the lowest, factor II at intermediate value, factors VII and IX the highest. Some 71% of the variance of the British corrected ratio (BCR) could be accounted for by measurement of the factors assayed. Analysis of this variance showed 91% of the explained variance attributable to factor II, 7% to factor VII, 1.6% to factor IX and 0.4% to factor X. With the sudden and recent withdrawal of human thromboplastin, investigation of the sensitivities of the animal thromboplastins to changes in vitamin K dependent factors in orally anticoagulated patients is needed to ensure that the potentially alarming falls in factors II and X in these patients are being adequately detected.This publication has 7 references indexed in Scilit:
- Evaluation of an Automated Prothrombin Assay Using a Chromogenic SubstratePathophysiology of Haemostasis and Thrombosis, 1984
- Oral anticoagulants.1981
- Oral AnticoagulantsClinics in Haematology, 1981
- An Evaluation of Chromogenic Substrates in the Control of Oral Anticoagulant TherapyBritish Journal of Haematology, 1981
- Standardization of Laboratory Tests for Controlling Anticoagulant TherapyAmerican Journal of Clinical Pathology, 1970
- Effect of Oral Anticoagulants on Factors VII, IX, X, and IIArchives of internal medicine (1960), 1965
- Behaviour of Factors II, VII, IX, and X during Long-Term Treatment with CoumarinThrombosis and Haemostasis, 1963